Nevertheless, central orexinergic system disruption through genetic or pharmacological manipulations that selectively target OX1R or OX2R results in opposite modulation of depression-like behavior (Scott et al. 2011). This evidence concerns the gene HCRTR1 and depressive symptom measurement.